| NDC Code | 51662-1337-3 |
|---|
| Package Description | 10 POUCH in 1 CASE (51662-1337-3) / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1337-2) / 20 mL in 1 VIAL, SINGLE-DOSE |
|---|
| Product NDC | 51662-1337 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Dobutamine |
|---|
| Non-Proprietary Name | Dobutamine |
|---|
| Dosage Form | INJECTION, SOLUTION, CONCENTRATE |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20181126 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA074086 |
|---|
| Manufacturer | HF Acquisition Co LLC, DBA HealthFirst |
|---|
| Substance Name | DOBUTAMINE HYDROCHLORIDE |
|---|
| Strength | 12.5 |
|---|
| Strength Unit | mg/mL |
|---|
| Pharmacy Classes | Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC] |
|---|